Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
- 3rd side (hint)
moa of macrolides
|
Inhibits protein synthesis by binding -reversibly to 50 S ribosomal subunit
-Interfere with binding of other antibiotics – clindamycin and chloramphenicol |
|
|
macrolides are statis or cidal
|
static,
cidal vs c. jejni |
|
|
t/f macrolides cover gram +: strep and staph but has no clinical evidence vs staph and is only tested in the club
|
true,
|
|
|
erythromycin covers
|
gram +
-strep -staph (not really) gram -: -campylobacter jejuni -moraxella catarrhalis -bordetella pertussis -n. gonorrhea other -atypicals + hb Legionella pneumophilia Mycoplasma pneumoniae Chalamydia pneumoniae Chlamydia trachomatis Treponema pallidum H. pylori Borrelia burgdorferi |
|
|
clarithyromycin covers
|
gram +
-strep -staph (not really) gram -: gram -: -campylobacter jejuni -moraxella catarrhalis -bordetella pertussis -n. gonorrhea -hemophilus influenza other -atypicals + hb+ mt Legionella pneumophilia Mycoplasma pneumoniae Chalamydia pneumoniae Chlamydia trachomatis H. pylori Borrelia burgdorferi Mycobacteria spp. Toxoplasma gondii Mycobacteria spp. |
|
|
how does gram - coverage differ b/t ery and clarith
|
- clarithyro covers ery gram - + hemophillus influenza
|
|
|
how does clarithy other coverage comp to erythy
|
- ery box (- treponema pallidum)
- + mycobacteria spp. , toxoplasma gondii |
|
|
azith spectrum of coverage
|
gram +
-strep -staph (not really) gram -: -campylobacter jejuni -moraxella catarrhalis -bordetella pertussis -n. gonorrhea -hemophilus influenza -ecoli -salmonella -shigella (clarith box + hess) other -atypicals + hb+ mt Legionella pneumophilia Mycoplasma pneumoniae Chalamydia pneumoniae Chlamydia trachomatis H. pylori Borrelia burgdorferi Mycobacteria spp. Toxoplasma gondii Mycobacteria spp. -treponema pallidum |
|
|
which abx covers treponema pallidum: ery, clarith, azith
|
covers: ery and azith
not: clarith |
|
|
macrolides cover gram + bacillus?
|
no
|
|
|
Macrolides are the doc for staph aures?
|
no, not 1st or 2nd line
|
|
|
macrolides are the doc for staph epi
|
no
|
remember staph coverage only dx tool
|
|
macrolides cover saprophyticus?
|
- no
|
|
|
macrolides cover strep pneumonia?
|
- yes
|
|
|
ery absorption
|
- Erratic, inactivated by gastric
acid (EC formulations) - better with salt form than base: (estolate>ethylsuccinate>stearat e) - F = low |
|
|
clarith absorption
|
Rapid absorption
- Acid stable |
|
|
azith absorption
|
- rapid absorption
- acid stable - f dec by food ( newly formulated tabs, may be taken w/out regard to food) |
|
|
macrolide distribution
|
distributes widely, except CSF
intracellular (phagocytes & macrophages)/tissue concentration >> plasma concentration (azithromycin [tissue] 10 -100 X > [plasma]) |
|
|
macrolide distribution in the blood?
|
- very little goes into the blood
- dnt give in bug is in the blood |
|
|
ery,clar and azith are eliminated by?
|
hepatic and renal
|
|
|
ery, clarith, azith
half life |
ery: 1.6 hrs
clar: 5-7 hrs azith: 68 hrs |
|
|
clarith elimination needs dosage adj?
|
yes, crcl <30 ml/min
- avoid use in severe hepatic impairment |
|
|
ery dosage frequency ?
|
q 6 hrs
|
|
|
clarith admin: biaxin xl w/ or w/out food
|
with food
|
|
|
clarith dosage frequency
|
po q 24 hrs
|
|
|
ery adr
|
- gi
-cholestatic hepatitis - otoxtoxicity -phlebitis |
|
|
clarith adr
|
- n/d/abd cramps
- metallic taste - inc liver enzymes |
|
|
azith adr
|
- n/d/adb cramps
- inc liver enzymes |
|
|
pregnancy categories
ery, clarith, azith |
- preg B: ery, azith
- preg C: clarith |
|
|
drug interactions of ery,clarith,azith
|
-Inhibition of CYP450 1A2 & 3A4
o Theophylline, cyclosporine, carbamazepine, warfarin, astemizole ...etc. (potential interaction with other substrates of these enzymes) - Inhibition of gut flora responsible for digoxin digestion (documented with E, caution with C & A) -Increased digoxin level -Competitive binding to 50 S ribosomal subunit o Antagonizes effects of clindamycin and chloramphenicol |
|
|
clarith covers community aquired pneumonia
|
yes
|
|
|
telithromycin moa
|
-Inhibits protein synthesis by binding to 23S ribosomal RNA of 50S ribosomal subunit
- 23S has 5 domains (I-V) - Clarithromycin and telithromycin binds to II and V |
|
|
telithromycin is static or cidal
|
static
|
|
|
telithromycin spectrum of activity
|
gram +
-staph aures -streptococcus: pneu, pyogenes gram - haemophilus influ moraxella catarrhalis inactive vs -enterobacteriaceae -psa aeruginosa other (atypicals) -chlamydophilia pneumoniae -legionella pneumophila -mycoplasma pneumoniae anaerobes -clostridium -peptostreptococcus -proprionibacterium -provetella |
gram -: hm
other: clm anaerobes 3p + c |
|
clinical indications for telithyromycin, explain the change
|
Before February 2007
-Community-acquired pneumonia (CAP) - Acute exacerbation of chronic bronchitis (AECB) - Acute bacterial sinusitis (ABS) After feb 12, 2007 Community-acquired pneumonia (CAP) |
|
|
absorption of telithy
|
- 90% absorption
|
|
|
metabolism of telith
|
- cyp 3a4 inhibitor
|
|
|
adr of telithromycin
|
- myasthenia gravis
- hepatotoxicity - visual disturbances - gi - cardiac: qtc prolongation - |
|
|
contraindications of telithromycin
|
- hepatotoxicity
|
|
|
bbw of telithromycin
|
- myasthenia gravis
|
|
|
telithromycin pregnancy category
|
preg cat c
|
|
|
inc telithromycin levels
|
- itraconazole
-ketoconazole |
|
|
dec telithromycin levels
|
-CRaPP
-carbamezapine -rifampin -phenobarbital -phenytoin |
|